MicroTech Medical tests appetite for HK$2bn IPO
Chinese diabetes device maker targets Hong Kong exchange's main board
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: